ADB-Butinaca

ADB-Butinaca (N-(1-Adamantyl)-1-(But-3-yn-1-yl)-1H-Indazole-3-Carboxamide)

High-Purity Synthetic Cannabinoid for Advanced Laboratory Research
ADB-Butinaca, also known as ADB-BUTINACA, is a synthetic cannabinoid of the indazole-3-carboxamide class — developed for scientific and pharmacological research into cannabinoid receptor activation and signaling pathways. It acts as a potent agonist at CB1 and CB2 receptors, making it a valuable tool for exploring the endocannabinoid systemand the neurochemical processes it regulates.

Scientific Overview
Researchers utilize ADB-Butinaca to investigate:Receptor binding affinities (CB1/CB2)⚙️ Pharmacodynamics of synthetic cannabinoidsNeurotransmitter modulationStructure-activity relationships (SAR)
Its selective receptor activity provides a reliable foundation for controlled studies into neurological response, behavioral pharmacology, and therapeutic potential modeling of cannabinoid-type compounds.

⚠️ Safety & Handling Notice

ADB-Butinaca is a highly potent research compound with limited toxicological and long-term safety data. It must only be handled by qualified professionals in certified laboratory environments under strict safety procedures.
Potential Risks Include:❗ Central nervous system overstimulation or dysregulation❗ Cardiovascular strain and unpredictable receptor response❗ Unknown metabolic and toxicological pathways
STRICTLY FOR RESEARCH USE ONLY

Not for human or animal consumption

Not for medical, therapeutic, or recreational use

Use only within legal, ethical, and controlled research settings

All experiments must comply with GLP standards, chemical handling regulations, and bioethics guidelines.

Key Features

✅ Analytical-grade purity for reproducible lab results✅ Valuable for cannabinoid receptor and SAR studies✅ Suitable for forensic, toxicological, and neurochemical research
ADB-Butinaca serves as a critical tool for scientists advancing our understanding of synthetic cannabinoid pharmacology and receptor-targeted neurochemistry. ⚗️